Daxor Corporation
Organization details
- Legal name
- Daxor Corporation
- Ownership
- Public
- Status
- Active
- Jurisdiction of incorporation
- New York
- Headquarters city
- OAK Ridge
- Headquarters state / province
- Tennessee
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- DXR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000027367
- EIN
- 13-2682108
Board of directors
-
Caleb DesRosiers · DirectorSince 2023
-
Edward Feuer · DirectorSince 2023
-
Henry D. Cremisi · DirectorSince 2023
-
James A. Lombard · DirectorSince 2023
-
Jonathan Adam Feldschuh · Director · Chief Scientific OfficerSince 2023
-
Joy S. Goudie · DirectorSince 2023
-
Michael Richard Feldschuh · Director · Chief Executive OfficerSince 2023
Chief executives
Director election results
Annual meeting of June 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.5%
-
92.6%
-
99.9%
-
99.9%
-
99.9%
-
99.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $18,970
- 6 purchases by 4 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 28, 2026 | Jefferies John Officer (Chief Medical Officer) | Grant or award | +2,451 | — | — |
| Jun 23, 2026 | Robert J. Michel Officer (Chief Financial Officer) | Grant or award | +12,000 | — | — |
| Jun 23, 2026 | Michael Richard Feldschuh Director, Officer (Chief Executive Officer) | Grant or award | +30,000 | — | — |
| Jun 23, 2026 | Jonathan Adam Feldschuh Director, Officer (Chief Scientific Officer) | Grant or award | +25,000 | — | — |
| Apr 8, 2026 | Michael Richard Feldschuh Director, Officer (Chief Executive Officer) | Open-market purchase | +1,000 | $9.07 | $9,070 |
| Mar 31, 2026 | Robert J. Michel Officer (Chief Financial Officer) | Open-market purchase | +1,000 | $9.90 | $9,900 |
| Mar 20, 2026 | Jefferies John Officer (Chief Medical Officer) | Open-market purchase | +3,656 | — | — |
| Mar 20, 2026 | Jefferies John Officer (Chief Medical Officer) | Open-market purchase | +2,285 | — | — |
| Dec 9, 2025 | Robert J. Michel Officer (Chief Financial Officer) | Open-market purchase | +3,000 | — | — |
| Dec 9, 2025 | Jonathan Adam Feldschuh Director, Officer (Chief Scientific Officer) | Open-market purchase | +18,000 | — | — |
| Nov 12, 2025 | Jefferies John Officer (Chief Medical Officer) | Open-market purchase | +2,344 | — | — |
| Apr 4, 2025 | Michael Richard Feldschuh Director, Officer (Chief Executive Officer) | Open-market purchase | +2,063 | $7.89 | $16,277 |
| Mar 10, 2025 | Robert J. Michel Officer (Chief Financial Officer) | Open-market purchase | +1,000 | $8.00 | $8,000 |
| Mar 10, 2025 | Michael Richard Feldschuh Director, Officer (Chief Executive Officer) | Open-market purchase | +3,360 | $7.68 | $25,805 |
| Dec 6, 2024 | Jonathan Adam Feldschuh Director, Officer (Chief Scientific Officer) | Open-market purchase | +32,000 | — | — |
Questions about Daxor Corporation
Who is the CEO of Daxor Corporation?
Michael Richard Feldschuh is Daxor Corporation's Chairman, President & CEO.
How many directors are on Daxor Corporation's board?
Daxor Corporation's board has 7 directors: Caleb DesRosiers, Edward Feuer, Henry D. Cremisi, James A. Lombard, Jonathan Adam Feldschuh, Joy S. Goudie and Michael Richard Feldschuh.
Are Daxor Corporation insiders buying or selling shares?
Over the last 12 months, Daxor Corporation insiders bought $18,970 of shares in 6 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="daxor-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.